The #FDA has granted fast track designation to ALE.P02 for treating patients with CLDN1-positive squamous solid tumors. https://lnkd.in/ewjn7GUK
Targeted Oncology的动态
更多文章
-
The Targeted Pulse: Discover Upcoming Meetings, FDA Action, and Key Insights in SCLC and mCSPC
-
The Targeted Pulse: A Review of Last Month’s FDA Prominent Actions and Key Data Updates Advancing Treatment Across Disease Types
-
The Targeted Pulse: Uncover the Latest From WCLC and Experts Insights Into Latest Advances Across Cancer Types